Koyfin Home > Directory > Health Care > Biogen Inc > EV / EBITDA (ntm)

Biogen Inc EV / EBITDA (ntm) Chart (BIIB)

Biogen Inc annual/quarterly EV / EBITDA (ntm) from 2010 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Biogen Inc EV / EBITDA (ntm) for the quarter ending November 11, 2020 was 9.61 a 2.92% increase of 0.28 year over year
  • Biogen Inc EV / EBITDA (ntm) for the last 12 months ending November 11, 2020 was 9.61 a 2.92% increase of 0.28 year over year
  • Biogen Inc Annual EV / EBITDA (ntm) for 2020 was 9.61 a 3.52% increase of 0.34 from 2019
  • Biogen Inc Annual EV / EBITDA (ntm) for 2020 was 9.27 a -0.29% decrease of -0.03 from 2019
  • Biogen Inc Annual EV / EBITDA (ntm) for 2020 was 9.30 a -0.33% decrease of -0.03 from 2019
Other Valuation Metrics:
  • Biogen Inc Market Cap for the quarter ending June 06, 2018 was $61,243m a -8.10% decrease of -4,961m year over year
  • Biogen Inc Price / Book for the quarter ending June 06, 2018 was 4.36 a -31.13% decrease of -1.36 year over year
  • Biogen Inc Enterprise Value for the quarter ending March 03, 2018 was $60,165m a -2.37% decrease of -1,425m year over year
View Chart On Koyfin

Quarterly BIIB EV / EBITDA (ntm) Data

11/20209.61
11/20209.27
11/20209.30
11/20209.33
11/20209.36
11/20209.35
11/20209.25
11/20209.52
11/20209.60
11/20209.52

Annual BIIB EV / EBITDA (ntm) Data

20209.61
20209.27
20209.30
20209.33
20209.36
20209.35
20209.25
20209.52
20209.60
20209.52